REGENERON PHARMACEUTICALS, INC.

All 13F Filings

Location
Tarrytown, NY
Most recent 13F
Q2 2026
Holdings value ($000)
177,219
Description
—
Website
—
Founded
—
Chairman
—
CEO
—
All SEC filings
View on sec.gov

Sector allocation over time (stocks only)

Stacked by quarter. Hover to see detailed sector breakdown for any quarter.

Quarter Date Filed Holdings Value ($000) Form Type Name
Q2 2026 8/7/2026 3 177,219 13F-HR REGENERON PHARMACEUTICALS, INC.
Q1 2026 5/8/2026 2 47,884 13F-HR REGENERON PHARMACEUTICALS, INC.
Q4 2025 2/6/2026 2 33,799 13F-HR REGENERON PHARMACEUTICALS, INC.
Q3 2025 11/7/2025 4 700,445 13F-HR REGENERON PHARMACEUTICALS, INC.
Q2 2025 8/1/2025 4 1,485,003 13F-HR REGENERON PHARMACEUTICALS, INC.
Swipe for more columns
Money flow by instrument (QoQ, ex-options)
Type Value ($000) Share % Inflow Outflow Net
Stocks 177.2 K 100.0% 129.3 K 0 129.3 K
Swipe for more columns

Fund Snapshot

Q2 2026
Latest filed
8/7/2026
Total value ($000)
177,219
Holdings
3
QoQ value change ($000)
129,335 (270.1%)
Value = total reported 13F value ($000), Holdings = number of positions.
13F Value over time
Holdings count over time
Sector allocation (latest, stocks only)
Methodology: sector allocation is stocks-only; instrument flow table is ex-options; options exposure is shown separately. Details.